Host Defense Response and Outcome in ARDS-Reference-Cited by-同舟云学术

Host Defense Response and Outcome in ARDS

Published:1997-11 Issue:5 Volume:112 Page:1154-1158
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Meduri G. Umberto

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference52 articles.

1. The role of the host defense response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment;Meduri;Eur Respir J,1996

2. Type III procollagen peptide in the adult respiratory distress syndrome: association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death;Clark;Ann Intern Med,1995

3. Type III procollagen peptide is present in pulmonary edema fluid on day one in patients with acute respiratory distress syndrome (ARDS) [abstract];Chesnut;Am J Respir Crit Care Med,1996

4. Pulmonary fibroblast function in an acute lung injury model;Mikulaschek;J Trauma,1995

5. The acute phase response;Baumann;Immunol Today,1994

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged glucocorticoid treatment in ARDS: Pathobiological rationale and pharmacological principles;Stress: Immunology and Inflammation;2024

2. Complicaties en andere gevolgen van mechanische beademing;Mechanische beademing op de intensive care;2024

3. Effect of Omega-3 fatty acids supplementation on serum level of C-reactive protein in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials;Journal of Translational Medicine;2022-09-05

4. Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19;Frontiers in Immunology;2021-03-30

5. Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?;British Journal of Cancer;2020-06-16